Investigating the potential of deep learning for patient-specific quality assurance of salivary gland contours using EORTC-1219-DAHANCA-29 clinical trial data

被引:9
作者
Nijhuis, Hanne [1 ]
van Rooij, Ward [1 ]
Gregoire, Vincent [2 ]
Overgaard, Jens [3 ]
Slotman, Berend J. [1 ]
Verbakel, Wilko F. [1 ]
Dahele, Max [1 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam UMC, Dept Radiat Oncol, Amsterdam, Netherlands
[2] Ctr Leon Berard, Dept Radiat Oncol, Lyon, France
[3] Aarhus Univ, Dept Expt Clin Oncol, Dept Clin Med, Aarhus N, Denmark
关键词
Deep learning; Radiotherapy; Clinical trial; Quality assurance; Segmentation; Salivary glands; RADIATION-THERAPY; RADIOTHERAPY;
D O I
10.1080/0284186X.2020.1863463
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Manual quality assurance (QA) of radiotherapy contours for clinical trials is time and labor intensive and subject to inter-observer variability. Therefore, we investigated whether deep-learning (DL) can provide an automated solution to salivary gland contour QA. Material and methods: DL-models were trained to generate contours for parotid (PG) and submandibular glands (SMG). Sorensen-Dice coefficient (SDC) and Hausdorff distance (HD) were used to assess agreement between DL and clinical contours and thresholds were defined to highlight cases as potentially sub-optimal. 3 types of deliberate errors (expansion, contraction and displacement) were gradually applied to a test set, to confirm that SDC and HD were suitable QA metrics. DL-based QA was performed on 62 patients from the EORTC-1219-DAHANCA-29 trial. All highlighted contours were visually inspected. Results: Increasing the magnitude of all 3 types of errors resulted in progressively severe deterioration/increase in average SDC/HD. 19/124 clinical PG contours were highlighted as potentially sub-optimal, of which 5 (26%) were actually deemed clinically sub-optimal. 2/19 non-highlighted contours were false negatives (11%). 15/69 clinical SMG contours were highlighted, with 7 (47%) deemed clinically sub-optimal and 2/15 non-highlighted contours were false negatives (13%). For most incorrectly highlighted contours causes for low agreement could be identified. Conclusion: Automated DL-based contour QA is feasible but some visual inspection remains essential. The substantial number of false positives were caused by sub-optimal performance of the DL-model. Improvements to the model will increase the extent of automation and reliability, facilitating the adoption of DL-based contour QA in clinical trials and routine practice.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 3 条
  • [1] Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance
    Tol, Jim P.
    Dahele, Max
    Gregoire, Vincent
    Overgaard, Jens
    Slotman, Ben J.
    Verbakel, Wilko F. A. R.
    RADIOTHERAPY AND ONCOLOGY, 2019, 130 : 75 - 81
  • [2] Deep Hybrid Learning Prediction of Patient-Specific Quality Assurance in Radiotherapy: Implementation in Clinical Routine
    Moreau, Noemie
    Bonnor, Laurine
    Jaudet, Cyril
    Lechippey, Laetitia
    Falzone, Nadia
    Batalla, Alain
    Bertaut, Cindy
    Corroyer-Dulmont, Aurelien
    DIAGNOSTICS, 2023, 13 (05)
  • [3] Virtual pretreatment patient-specific quality assurance of volumetric modulated arc therapy using deep learning
    Yoganathan, S. A.
    Ahmed, Sharib
    Paloor, Satheesh
    Torfeh, Tarraf
    Aouadi, Souha
    Al-Hammadi, Noora
    Hammoud, Rabih
    MEDICAL PHYSICS, 2023, 50 (12) : 7891 - 7903